🔎 Trials Near Me

Akèy › Limfòm folikilè › Minnesota › Rochester

Etid klinik pou Limfòm folikilè nan Rochester, MN

10 etid pou Limfòm folikilè ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Ap rekriteFaz 1/2
  • Research Site, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06542250

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Ap rekriteFaz 1/2
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05006716

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Ap rekriteFaz 1
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Ap rekriteFaz 2
  • Research Site, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06526793

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • Mayo Clinic, Clinical Trials Referral Office, Rochester
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Ap rekriteFaz 1/2
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07468136

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Ap rekriteFaz 1/2
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT04669171

Q702 for the Treatment of Patients With Hematologic Malignancies

Ap rekriteFaz 1
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Oct 10, 2025 · NCT06712810

Etid Limfòm folikilè nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.